In a cohort of Greek patients with moderate-to-severe psoriasis (n = 228), the rs10484554 polymorphism in the HLA-C gene was associated with a better response to anti-TNF-α, as well as the HLA-A-rs610604 polymorphism with a better response to adalimumab [90]. The gene discussed is HLA-C; the disease is psoriasis.